HSE approves 'groundbreaking' cystic fibrosis drug for children aged 6-11

A demonstration at Leinster House last September calling for the availability of Kaftrio for children with cystic fibrosis. File picture: Shane O'Neill

The families of 35 children with cystic fibrosis are celebrating after the drug Kaftrio was approved by the HSE for use by children aged between 6-11.

The drug had previously been excluded from the children within this age bracket. It has now been extended for use following lengthy engagements with the drug manufacturer Vertex.